Eli Lilly and Company's Fiscal Year is From January To December - All Figures are in Percent.
The item "Return-On-Assets" stands at 19.18 percent as of 09/30/2025, the highest value at least since 06/30/2022, the period currently displayed.
As of the end of Eli Lilly and Company's third quarter, the item "Return On Assets" stands at 19.18 Percent. This represents an increase of 3.16 percentage points compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 7.03 percentage points compared to the value the year prior.
The 1 year change in percentage points is 7.03.
The 3 year change in percentage points is 6.50.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Johnson & Johnson - Return On Assets | 486,508,953,600.00 |
![]() | AbbVie Inc - Return On Assets | 399,570,305,024.00 |
![]() | Roche Holding AG - Return On Assets | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Return On Assets | 280,205,508,085.11 |
![]() | Novartis AG - Return On Assets | 255,096,620,580.91 |